Tweddle DA - Search Results

1

Influence of segmental chromosome abnormalities on survival in children over the age of 12 months with unresectable localised peripheral neuroblastic tumours without MYCN amplification.

Defferrari R, Mazzocco K, Ambros IM, Ambros PF, Bedwell C, Beiske K, Bénard J, Berbegall AP, Bown N, Combaret V, Couturier J, Erminio G, Gambini C, Garaventa A, Gross N, Haupt R, Kohler J, Jeison M, Lunec J, Marques B, Martinsson T, Noguera R, Parodi S, Schleiermacher G, Tweddle DA, Valent A, Van Roy N, Vicha A, Villamon E, Tonini GP. Defferrari R, et al. Among authors: tweddle da. Br J Cancer. 2015 Jan 20;112(2):290-5. doi: 10.1038/bjc.2014.557. Epub 2014 Nov 4. Br J Cancer. 2015. PMID: 25356804 Free PMC article.

2

Evidence for the development of p53 mutations after cytotoxic therapy in a neuroblastoma cell line.

Tweddle DA, Malcolm AJ, Bown N, Pearson AD, Lunec J. Tweddle DA, et al. Cancer Res. 2001 Jan 1;61(1):8-13. Cancer Res. 2001. PMID: 11196202

3

p53 cellular localization and function in neuroblastoma: evidence for defective G(1) arrest despite WAF1 induction in MYCN-amplified cells.

Tweddle DA, Malcolm AJ, Cole M, Pearson AD, Lunec J. Tweddle DA, et al. Am J Pathol. 2001 Jun;158(6):2067-77. doi: 10.1016/S0002-9440(10)64678-0. Am J Pathol. 2001. PMID: 11395384 Free PMC article.

4

The p53 pathway and its inactivation in neuroblastoma.

Tweddle DA, Pearson AD, Haber M, Norris MD, Xue C, Flemming C, Lunec J. Tweddle DA, et al. Cancer Lett. 2003 Jul 18;197(1-2):93-8. doi: 10.1016/s0304-3835(03)00088-0. Cancer Lett. 2003. PMID: 12880966 Review.

5

Increased frequency of aberrations in the p53/MDM2/p14(ARF) pathway in neuroblastoma cell lines established at relapse.

Carr J, Bell E, Pearson AD, Kees UR, Beris H, Lunec J, Tweddle DA. Carr J, et al. Among authors: tweddle da. Cancer Res. 2006 Feb 15;66(4):2138-45. doi: 10.1158/0008-5472.CAN-05-2623. Cancer Res. 2006. PMID: 16489014

6

The role of MYCN in the failure of MYCN amplified neuroblastoma cell lines to G1 arrest after DNA damage.

Bell E, Premkumar R, Carr J, Lu X, Lovat PE, Kees UR, Lunec J, Tweddle DA. Bell E, et al. Among authors: tweddle da. Cell Cycle. 2006 Nov;5(22):2639-47. doi: 10.4161/cc.5.22.3443. Epub 2006 Nov 15. Cell Cycle. 2006. PMID: 17172827

7

High-resolution analysis of allelic imbalance in neuroblastoma cell lines by single nucleotide polymorphism arrays.

Carr J, Bown NP, Case MC, Hall AG, Lunec J, Tweddle DA. Carr J, et al. Among authors: tweddle da. Cancer Genet Cytogenet. 2007 Jan 15;172(2):127-38. doi: 10.1016/j.cancergencyto.2006.08.012. Cancer Genet Cytogenet. 2007. PMID: 17213021

8

Cell cycle regulation targets of MYCN identified by gene expression microarrays.

Bell E, Lunec J, Tweddle DA. Bell E, et al. Among authors: tweddle da. Cell Cycle. 2007 May 15;6(10):1249-56. doi: 10.4161/cc.6.10.4222. Epub 2007 May 1. Cell Cycle. 2007. PMID: 17495526

9

Identification of candidate genes involved in neuroblastoma progression by combining genomic and expression microarrays with survival data.

Łastowska M, Viprey V, Santibanez-Koref M, Wappler I, Peters H, Cullinane C, Roberts P, Hall AG, Tweddle DA, Pearson AD, Lewis I, Burchill SA, Jackson MS. Łastowska M, et al. Among authors: tweddle da. Oncogene. 2007 Nov 22;26(53):7432-44. doi: 10.1038/sj.onc.1210552. Epub 2007 May 28. Oncogene. 2007. PMID: 17533364

10

p53 is nuclear and functional in both undifferentiated and differentiated neuroblastoma.

Chen L, Malcolm AJ, Wood KM, Cole M, Variend S, Cullinane C, Pearson AD, Lunec J, Tweddle DA. Chen L, et al. Among authors: tweddle da. Cell Cycle. 2007 Nov 1;6(21):2685-96. doi: 10.4161/cc.6.21.4853. Epub 2007 Aug 10. Cell Cycle. 2007. PMID: 17912039

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

74 results

Search Page